Author Response: Morphine Disinhibits Glutamatergic Input to VTA Dopamine Neurons and Promotes Dopamine Neuron Excitation
Ming Chen,Ying Zhao,Hualan Yang,Wenjie Luan,Jiaojiao Song,Dongyang Cui,Yi Dong,Bin Lai,Lan Ma,Ping Zheng
DOI: https://doi.org/10.7554/elife.09275.016
2015-01-01
Abstract:Article Figures and data Abstract eLife digest Introduction Results Discussion Materials and methods References Decision letter Author response Article and author information Metrics Abstract One reported mechanism for morphine activation of dopamine (DA) neurons of the ventral tegmental area (VTA) is the disinhibition model of VTA-DA neurons. Morphine inhibits GABA inhibitory neurons, which shifts the balance between inhibitory and excitatory input to VTA-DA neurons in favor of excitation and then leads to VTA-DA neuron excitation. However, it is not known whether morphine has an additional strengthening effect on excitatory input. Our results suggest that glutamatergic input to VTA-DA neurons is inhibited by GABAergic interneurons via GABAB receptors and that morphine promotes presynaptic glutamate release by removing this inhibition. We also studied the contribution of the morphine-induced disinhibitory effect on the presynaptic glutamate release to the overall excitatory effect of morphine on VTA-DA neurons and related behavior. Our results suggest that the disinhibitory action of morphine on presynaptic glutamate release might be the main mechanism for morphine-induced increase in VTA-DA neuron firing and related behaviors. https://doi.org/10.7554/eLife.09275.001 eLife digest Morphine is one of the most commonly used drugs for the treatment of severe pain. It is derived from opium, which is extracted from poppies, and binds to the same receptors in the brain as the body's own naturally produced painkillers. As well as providing pain relief, morphine can act directly on the brain's reward system to trigger a state of euphoria, and can therefore be highly addictive. One of the key components of the brain's reward circuit that morphine affects is called the ventral tegmental area (VTA). The activity of the VTA is regulated by the combined efforts of two groups of cells: excitatory glutamatergic neurons that increase VTA activity and inhibitory interneuronsthat reduce the activity of the VTA. Morphine inhibits the interneurons, thereby allowing the glutamatergic neurons to activate the VTA. But does morphine also strengthen this excitatory input directly? By examining the effects of morphine on individual VTA neurons, Chen et al. show that the drug does indeed enhance the activity of the glutamatergic neurons. However, it does so indirectly by inhibiting another group of interneurons that would otherwise silence the glutamatergic neurons. This effect of morphine is dependent on the drug acting on a specific receptor type on the interneurons. Chen et al. show that injecting a drug that blocks these receptors straight into the VTA of rats prevents morphine from increasing the animals' activity levels. It also prevents the animals from developing a preference for being in locations where they have previously received morphine. This suggests that morphine could primarily exert its pleasurable effects by preventing the glutamatergic neurons from being inhibited, and thus allowing them to activate the VTA neurons. https://doi.org/10.7554/eLife.09275.002 Introduction Morphine is a potent analgesic with high addictive potential. Morphine-induced addictive behaviors are strongly dependent on the activation of dopamine (DA) neurons of the ventral tegmental area (VTA) (Wise, 1989; Gardner, 2011; Luscher and Malenka, 2011). The hedonic response produced by the activation of VTA-DA neurons by morphine is a primary factor behind drug dependence. One previously reported mechanism for morphine activation of VTA-DA neurons is the VTA-DA neuron disinhibition model (Johnson and North, 1992; Kalivas, 1993; White, 1996). Morphine first inhibits neighboring GABA inhibitory neurons, which shifts the balance between inhibitory and excitatory input to VTA-DA neurons in favor of excitation and then leads to the promotion of VTA-DA neuron excitation. It was also reported that the release of glutamate from least some of the glutamate terminals that synapsed on VTA-DA neurons was inhibited by opioids (Manzoni and Williams, 1999; Margolis et al., 2005). This inhibitory effect of opioids on glutamate release is puzzling (Chartoff and Connery, 2014) because one would expect morphine to produce rapid activation of VTA-DA neurons through both the inhibition of GABAergic input and the excitation of glutamatergic input. In addition, postsynaptic inhibition (Ford et al., 2006) or excitation (Margolis et al., 2014) in response to μ opioid receptor activation has also been reported in some VTA-DA neurons. However, the amplitude of the inhibitory outward currents produced by opioids in postsynaptic VTA-DA neurons in the study of Ford et al. was small (2.1 ± 1.5 pA in VTA-DA neurons projecting to the nucleus accumbens and 14 ± 4 pA in those projecting to the basolateral amygdaloid nucleus) (Ford et al., 2006), while only a small population of VTA-DA neurons (19%) showed depolarization or an increase in firing rate in response to opioids in the study of Margolis et al. (2014). This low postsynaptic responsiveness to opioids was consistent with physiological and anatomical evidence that only a few VTA-DA neurons had µ receptors (Ford et al., 2006). Here, we propose that morphine might have a strengthening, rather than an inhibitory, effect on glutamatergic input to VTA-DA neurons because it was reported that blockade of excitatory glutamatergic signaling in the VTA suppressed morphine-induced VTA-DA neuron activation (Jalabert et al., 2011) and related behaviors (Kalivas and Alesdatter, 1993; Harris and Aston-Jones, 2003; Harris et al., 2004). Moreover, the strengthening influence of morphine on glutamatergic input to VTA-DA neurons is more relevant to its promoting effect on VTA-DA neuron excitation. In this article, we report our observations of the effect of morphine on glutamatergic input to VTA-DA neurons using the whole-cell patch-clamp method, and the results of our study of its mechanism and functional consequences using electrophysiological, biochemical, optogenetic, pharmacological, and behavioral approaches. Results Morphine-induced increase in spontaneous firing frequency of VTA-DA neurons is dependent on glutamatergic input We observed the effect of morphine (10 µM) on the spontaneous firing frequency of VTA-DA neurons in rats. We select 10 µM of morphine because this concentration is commonly used in in vitro experiments as it elicits a significant effect useful for further analyses (Akaishi et al., 2000), and the effect of morphine at this concentration can be essentially abolished by the opioid receptor antagonist naloxone (Valentino and Dingledine, 1982). VTA-DA neurons were identified based on Ih currents (Figure 1A) and tyrosine hydroxylase (TH) staining (Figure 1B). Details of the identification method are given in the ‘Materials and methods’ section. Using original recordings of spontaneous firing (left panel of Figure 2A) and the time course of spontaneous firing (middle panel of Figure 2A) in VTA-DA neurons for comparison, we could see that morphine (10 μM) increased the frequency of spontaneous firing in VTA-DA neurons. The average frequency of spontaneous firing increased from 1.0 ± 0.3 Hz before to 1.4 ± 0.4 Hz for 10–15 min after morphine application (n = 6 cells from five rats, paired t test, p < 0.05, compared to control before morphine, right panel of Figure 2A). In order to determine the role of glutamatergic input in the morphine-induced increase in the spontaneous firing frequency of VTA-DA neurons, we observed the influence of the N-methyl-D-aspartic acid (NMDA) receptor antagonist DL-2-amino-5-phosphonovaleric acid (APV) (50 μM) and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist 6, 7-Dinitroquinoxalie-2, 3-dione (DNQX) (10 μM) on the effect of morphine. In the presence of APV and DNQX, morphine no longer increased spontaneous firing frequency (Figure 2B). The average frequency of spontaneous firing was 0.7 ± 0.1 Hz before and 0.8 ± 0.1 Hz for 10–15 min after morphine application in the presence of APV and DNQX (n = 6 cells from five rats, paired t test, p > 0.05, compared to control with APV and DNQX before morphine, right panel of Figure 2B). These results suggest that the morphine-induced increase in the spontaneous firing frequency of VTA-DA neurons requires AMPA and NMDA receptor-mediated glutamatergic input, consistent with a recent report using the NMDA antagonist APV and the AMPA receptor antagonist 6-Cyano-7-nitroquinoxaline-2, 3-dione (CNQX) in in vivo experiments (Jalabert et al., 2011). Figure 1 Download asset Open asset Identification of VTA-DA neurons in rats. (A) Electrophysiological properties of VTA-DA neurons. Left panel: representative traces showing a large hyperpolarization-activated current (Ih) in whole-cell voltage-clamp recording. Holding potential: −70 mV. Right panel: representative traces showing a large voltage ‘sag’ when hyperpolarized in whole-cell current-clamp recording. Holding current: 0 pA. (B) Immunohistochemical labeling of identified VTA-DA neurons. Panel 1: images of a Lucifer yellow-labeled neuron from the ventral tegmental area (VTA) after whole-cell patch-clamp recording under infrared differential interference contrast and fluorescent microscopy. Panel 2: the same neuron labeled with Lucifer yellow (green color) under confocal microscopy. Panel 3: VTA images showing tyrosine hydroxylase (TH)-positive neurons after immunostaining. Panel 4: Lucifer yellow-filled neuron co-labeled with TH. Scale bar: 20 μm. https://doi.org/10.7554/eLife.09275.003 Figure 2 Download asset Open asset Effect of morphine on spontaneous firing of VTA-DA neurons in rats and the influence of the NMDA receptor antagonist APV and the AMPA receptor antagonist DNQX on the effect of morphine on spontaneous firing of VTA-DA neurons in rats. (A) Effect of morphine on spontaneous firing of VTA-DA neurons. Left panel: representative spontaneous firing traces before and after morphine (10 μM). Middle panel: time course of spontaneous firing before and after morphine (10 μM) (n = 6 cells from five rats). Right panel: average frequency of spontaneous firing before and after morphine (n = 6 cells from five rats, p < 0.05, compared to control before morphine). (B) Influence of the NMDA receptor antagonist APV and the AMPA receptor antagonist DNQX on the effect of morphine on spontaneous firing in VTA-DA neurons. Left panel: representative spontaneous firing traces before and after morphine (10 μM) in the presence of APV (50 μM) and DNQX (10 μM). Middle panel: time course of spontaneous firing before and after morphine in the presence of APV (50 μM) and DNQX (10 μM) (n = 6 cells from five rats). Right panel: average frequency of spontaneous firing before and after morphine in the presence of APV (50 μM) and DNQX (10 μM) (n = 6 cells from five rats, p = 0.34). Data are shown as the mean ±s.e.m. *p < 0.05. https://doi.org/10.7554/eLife.09275.004 Morphine has an additional promoting effect on presynaptic glutamate release in VTA-DA neurons In order to study the effect of morphine on glutamatergic input to VTA-DA neurons, we examined the effect of morphine on the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) in VTA-DA neurons in rats. First, we observed the effect of morphine on the frequency of sEPSCs when the GABAA receptor antagonist picrotoxin (PTX) was added to a bath solution to remove spontaneous inhibitory postsynaptic currents (sIPSCs). Consistent with earlier reports (Manzoni and Williams, 1999; Margolis et al., 2005), in the presence of extracellularly applied PTX (100 μM), morphine (10 μM) decreased the frequency of sEPSCs (Figure 3A). The average frequency of sEPSCs decreased from 4.2 ± 0.7 Hz before to 3.5 ± 0.7 Hz for 10–15 min after morphine application (n = 6 cells from four rats, paired t test, p < 0.05, compared to control before morphine, right panel of Figure 3A). However, bath application of GABAA receptor antagonists can lead to a wide blocking effect on GABAA receptors present on different types of neurons, including DA-neurons and GABA neurons, in VTA slices. To circumvent this wide influence and target the inhibition of GABAA receptors to VTA-DA neurons, we added the GABAA receptor antagonist PTX (100 µM) to the internal solution of microelectrodes as described by Akaike et al. (1985) when recording sEPSCs. To demonstrate the effectiveness of the blockade of GABAA receptors by intracellularly applied PTX, we first examined the effect of intracellularly applied PTX (100 μM) on inhibitory postsynaptic currents (IPSC) in VTA-DA neurons. The results showed that under this experimental paradigm, IPSCs disappeared (top of panel 1 in Figure 3B, n = 5 cells from two rats), demonstrating that GABAA receptors in the recorded VTA-DA neurons were blocked by intracellularly applied PTX. In addition, to further confirm that the spontaneous events we measured in the presence of intracellularly applied PTX were in fact sEPSCs, we observed the effect of the AMPA receptor antagonist DNQX on spontaneous events in the presence of intracellularly applied PTX. The results showed that the spontaneous events were completely blocked by DNQX (10 μM) (bottom of panel 1 in Figure 3B). We repeated the experiment in three cells from different slices and obtained similar results. On this basis, we observed the effect of morphine on the sEPSCs in the presence of intracellularly applied PTX. Raw current traces (panel 2 of Figure 3B) and the time course of sEPSCs (panel 3 of Figure 3B) before and after morphine application in the presence of intracellularly applied PTX showed that morphine (10 μM) increased the frequency of sEPSCs. The average frequency of sEPSCs increased from 4.8 ± 0.6 Hz before to 5.5 ± 0.6 Hz for 10–15 min after morphine application (n = 8 cells from five rats, paired t test, p < 0.05, compared to control before morphine, panel 4 of Figure 3B). However, morphine (10 μM) had no significant effect on the amplitude of sEPSCs. The average amplitude of sEPSCs was 16.6 ± 1.3 pA before and 15.3 ± 1.3 pA for 10–15 min after morphine application (n = 8 cells from five rats, paired t test, p > 0.05, compared to control before morphine, panel 5 of Figure 3B). To confirm that the increased spontaneous events we measured in the presence of intracellularly applied PTX after morphine were also in fact sEPSCs, we observed the effect of the AMPA receptor antagonist DNQX on spontaneous events after morphine application in the presence of intracellularly applied PTX. The results showed that the spontaneous events after morphine application were completely blocked by adding DNQX (10 μM) (panel 6 of Figure 3B). We repeated the experiment in three cells from different slices and obtained similar results. We also used the first excitatory postsynaptic current (EPSC) of paired pulse facilitation (PPF) as an index of EPSC (Maejima et al., 2001), and the PPF of paired EPSC as an indicator of presynaptic glutamate release (Zucker and Regehr, 2002) to confirm the effect of morphine on presynaptic glutamate release in VTA-DA neurons in the presence of intracellularly applied PTX. As shown in the left panel of Figure 3C, morphine (10 μM) increased the amplitude of the first EPSC, which was accompanied by a clear change in the presynaptic parameter PPF. The average amplitude of the first EPSCs was 124.1 ± 9.0 pA before and 161.9 ± 10.8 pA for 10–15 min after morphine application (n = 6 cells from four rats, paired t test, p < 0.05, compared to control before morphine, middle panel of Figure 3C). The average PPF was decreased from 1.5 ± 0.2 before to 1.2 ± 0.1 for 10–15 min after morphine application (n = 6 cells from four rats, paired t test, p < 0.05, compared to control before morphine, right panel of Figure 3C). These results supported the suggestion that morphine increased presynaptic glutamate release in VTA-DA neurons in the presence of intracellularly applied PTX. More importantly, when we clamped the membrane potential of VTA-DA neurons at the reversal potential of Cl− channels to remove sIPSCs, as an alternative to the application of a GABAA antagonist, either by the intracellular or bath approach, morphine still exerted a promoting effect on presynaptic glutamate release in VTA-DA neurons (Figure 3D). The average frequency of sEPSCs in this condition increased from 4.4 ± 0.3 Hz before to 5.5 ± 0.4 Hz for 10–15 min after morphine application (n = 6 cells from four rats, paired t test, p < 0.05, compared to control before morphine, right panel of Figure 3D). Figure 3 Download asset Open asset Effects of morphine on the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) and paired pulse facilitation (PPF) of VTA-DA neurons in rats. (A) Effects of morphine on the frequency of sEPSCs in the presence of extracellularly applied picrotoxin (PTX) in VTA-DA neurons. Left panel: typical current traces of sEPSCs before and after morphine (10 μM) in the presence of extracellularly applied PTX. Middle panel: typical time course of the frequency of sEPSCs before and after morphine (10 μM) in the presence of extracellularly applied PTX. Right panel: average frequency of sEPSCs before and after morphine (10 μM) in the presence of extracellularly applied PTX (n = 6 cells from four rats, p < 0.05, compared to control before morphine). (B) Effects of morphine on sEPSCs in the presence of intracellularly applied PTX in VTA-DA neurons. Top of panel 1: inhibitory postsynaptic currents (IPSCs) in the normal intracellular recording solution and the presence of intracellularly applied PTX. Bottom of panel 1: typical current traces of sEPSCs before and after DNQX (10 μM) in the presence of intracellularly applied PTX. Panel 2: typical current traces of sEPSCs before and after morphine (10 μM) in the presence of intracellularly applied PTX. Panel 3: typical time course of the frequency of sEPSCs before and after morphine (10 μM) in the presence of intracellularly applied PTX. Panel 4: average frequency of sEPSCs before and after morphine (10 μM) in the presence of intracellularly applied PTX (n = 8 cells from five rats, p < 0.05, compared to control before morphine). Panel 5: average amplitude of sEPSCs before and after morphine (10 μM) in the presence of intracellularly applied PTX (n = 8 cells from five rats, p = 0.24, compared to control before morphine). Panel 6: typical current traces of sEPSCs before and after DNQX (10 μM) in the presence of intracellularly applied PTX and morphine. (C) Effects of morphine on the PPF in VTA-DA neurons. Left panel: representative traces of the PPF before and after morphine (10 μM), and superimposition of the two traces normalized to the first excitatory postsynaptic current (EPSC) before and after morphine (10 μM) in the presence of intracellularly applied PTX. Middle panel: average amplitude of the first EPSC in control and morphine (10 μM) in the presence of intracellularly applied PTX (n = 6 cells from four rats, p < 0.05, compared to control before morphine). Right panel: average PPF before and after morphine (10 μM) in the presence of intracellularly applied PTX (n = 6 cells from four rats, p < 0.05, compared to control before morphine). (D) Effects of morphine on the frequency of sEPSCs when VTA-DA neurons were clamped the membrane potential at the reversal potential of Cl− channels in VTA-DA neurons. Left panel: typical current traces of sEPSCs before and after morphine (10 μM) when DA neurons was clamped the membrane potential at the reversal potential of Cl− channels. Middle panel: typical time course of the frequency of sEPSCs before and after morphine (10 μM) when DA neurons was clamped the membrane potential at the reversal potential of Cl− channels. Right panel: average frequency of sEPSCs before and after morphine (10 μM) when DA neurons was clamped the membrane potential at the reversal potential of Cl− channels (n = 6 cells from four rats, p < 0.05, compared to control before morphine). Data are shown as the mean ±s.e.m. *p < 0.05. https://doi.org/10.7554/eLife.09275.005 Morphine promotes presynaptic glutamate release in VTA-DA neurons via presynaptic disinhibition The mechanism underlying the promoting effect of morphine on presynaptic glutamate release in VTA-DA neurons may involve different processes. One suggestion is that morphine may directly act at glutamatergic terminals to promote glutamate release. To test this hypothesis, we studied the effect of morphine on glutamate release from the VTA synaptosomes of rats, which are sealed particles containing vesicles, viable mitochondria, and all components necessary to store, release, and retain neurotransmitters (Breukel et al., 1997), using on-line fluorometry. However, we did not find that morphine (10 μM) had a direct effect at glutamatergic terminals to promote glutamate release. The average concentration of glutamate was 8.1 ± 0.1 nmol/mg before and 8.5 ± 0.7 nmol/mg after morphine application (n = 6 samples from eight rats, paired t test, p > 0.05, Figure 4A). We also studied the effect of morphine on the frequency of sEPSCs from mechanically dissociated single VTA-DA neurons in rats, which retained functional synaptic terminals (Akaike and Moorhouse, 2003; Ye et al., 2004; Deng et al., 2009). The left top image of panel 1 of Figure 4B shows mechanically dissociated neurons from the VTA. These VTA-DA neurons were identified by only using Ih currents (the graph on the right of panel 1 of Figure 4B) without TH staining because in dissociated DA neurons, it was difficult to fix the cell after recording for TH staining. The results showed that morphine (10 µM) had no significant effect on the frequency of sEPSCs (panels 2 and 3 of Figure 4B). The average frequency of sEPSCs was 2.1 ± 0.3 Hz before and 2.0 ± 0.2 Hz for 10–15 min after morphine application (10 µM) (n = 6 cells from six rats, paired t test, p > 0.05, compared to control before morphine, panel 4 of Figure 4B). These results suggest that morphine may promote presynaptic glutamate release in VTA-DA neurons in an indirect way. Figure 4 Download asset Open asset Effects of morphine on glutamate release from the ventral tegmental area (VTA) synaptosomes of rats and the frequency of sEPSCs in mechanically dissociated VTA-DA neurons from rats. (A) Effects of morphine on glutamate release from VTA synaptosomes. Average concentration of glutamate release before and after application of morphine (10 μM) from VTA synaptosomes (n = 6 samples from eight rats, p = 0.46). (B) Effects of morphine on the frequency of sEPSCs in mechanically dissociated VTA-DA neurons. Panel 1, left: images of an acutely dissociated single neuron from the VTA under phase contrast microscopy. Scale bar: 10 μm. Panel 1, right: representative current traces showing a large hyperpolarization-activated current (Ih) in whole-cell voltage-clamp recording. Holding potential: −70 mV. Panel 2: typical current traces of sEPSC before and after morphine (10 μM) in the presence of intracellularly applied PTX. Panel 3: typical time course of the frequency of sEPSCs before and after morphine (10 μM) in the presence of intracellularly applied PTX. Panel 4: Average frequency of sEPSCs before and after morphine (10 μM) in the presence of intracellularly applied PTX (n = 6 cells from six rats, p = 0.65). Data are shown as the mean ±s.e.m. *p < 0.05. https://doi.org/10.7554/eLife.09275.006 To explore how morphine promoted presynaptic glutamate release in VTA-DA neurons, we hypothesized that glutamatergic input to VTA-DA neurons was inhibited by GABAergic interneurons and morphine disinhibited glutamatergic input by removing this inhibition, thus promoting glutamate release. To test this hypothesis, we first studied whether GABA could inhibit presynaptic glutamate release in VTA-DA neurons by examining the effect of exogenous applied of GABA on the frequency of sEPSCs of VTA-DA neurons in rats. From raw current traces (left panel of Figure 5A) and the time course of sEPSCs (middle panel of Figure 5A), we could see that GABA (10 μM) apparently decreased the frequency of sEPSCs. The average frequency of sEPSCs decreased from 6.7 ± 0.7 Hz before to 4.7 ± 0.6 Hz for 10–15 min after GABA application (n = 6 cells from four rats, paired t test, p < 0.05, compared to control before GABA, right panel of Figure 5A). Then, we observed whether the activation of intrinsic GABAergic neurons could inhibit presynaptic glutamate release of VTA-DA neurons in mice. To do this, AAV virus expressing a double floxed-stopped channelrhodopsin-2 (ChR2)-mCherry was stereotaxically injected into the VTA of mice expressing Cre recombinase in GABA neurons. 2 weeks after infection, expression of ChR2–mCherry was observed in the VTA (panel 1 of Figure 5B). We then performed whole-cell patch-clamp recording in GABA neurons of the VTA and observed the light-induced action potentials in GABA neurons in order to confirm that ChR2 was indeed expressed in the GABA neurons of the VTA in mice. The results showed that 470 nm light stimulation (20 Hz) elicited action potentials in GABA neurons (panel 2 of Figure 5B). On this basis, whole-cell patch-clamp recording was performed in VTA-DA neurons to observe the effect of 470 nm light stimulation on the frequency of sEPSCs in the presence of intracellularly applied PTX (100 µM). Following 5–10 min of baseline recording of sEPSCs, twenty 470 nm light pulses of 5 ms at 20 Hz were delivered every 4 s for 15 min. Raw current traces (panel 3 of Figure 5B) and the time course of sEPSCs (panel 4 of Figure 5B) before and after light stimulation showed that the light stimulation apparently decreased the frequency of sEPSCs. The average frequency of sEPSCs decreased from 4.1 ± 0.7 Hz before to 2.7 ± 0.3 Hz for 10–15 min after light stimulation (n = 6 cells from five mice, paired t test, p < 0.05, compared to control before light stimulation, panel 5 of Figure 5B). Figure 5 Download asset Open asset Effect of exogenous application of GABA and 470 nm light stimulation on the frequency of sEPSCs in the presence of intracellularly applied PTX in VTA-DA neurons. (A) Effect of exogenous application of GABA on the frequency of sEPSCs of VTA-DA neurons in rats. Left panel: typical current traces of sEPSCs before and after GABA (10 μM) in the presence of intracellularly applied PTX. Middle panel: typical time course of the frequency of sEPSCs before and after GABA (10 μM) in the presence of intracellularly applied PTX. Right panel: average frequency of sEPSCs before and after GABA (10 μM) in the presence of intracellularly applied PTX (n = 6 cells from four rats, p < 0.05, compared to control before GABA). (B) Effect of 470 nm light stimulation on the frequency of sEPSCs of VTA-DA neurons in mice. Panel 1: coronal image showing the expression of ChR2-mCherry (red) following injection of the viral construct bilaterally into the ventral tegmental area (VTA) of GADcre+ mice. Scale bar: 500 µm. Panel 2: 470 nm light (20 Hz)-induced firing of VTA GABA neurons in current-clamp mode. Panel 3: typical current traces of sEPSCs before and after blue light (470 nm) stimulation in the presence of intracellularly applied PTX. Panel 4: typical time course of the frequency of sEPSCs before and after blue light (470 nm) stimulation in the presence of intracellularly applied PTX. Panel 5: average frequency of sEPSCs before and after blue light (470 nm) stimulation in the presence of intracellularly applied PTX (n = 6 cells from five mice, p < 0.05, compared to control before light stimulation). Data are shown as the mean ±s.e.m. *p < 0.05. https://doi.org/10.7554/eLife.09275.007 We also studied which kinds of GABA receptors (GABAA or GABAB receptors) mediated the decreasing effect of GABA on presynaptic glutamate release in VTA-DA neurons by examining the influence of the GABAA or GABAB receptor antagonist on the effect of GABA on the frequency of sEPSCs in rats. The results showed that the GABAA receptor antagonist PTX (100 µM) had no significant influence on the effect of GABA (Figure 6A). The average frequency of sEPSCs still decreased from 4.0 ± 0.3 Hz before to 3.0 ± 0.2 Hz for 10–15 min after GABA application in the presence of PTX (n = 6 cells from four rats, paired t test, p < 0.05, compared to PTX before GABA, right panel of Figure 6A). The percentage of GABA-produced response in the presence of PTX (−25.8 ± 3.8%) was not statistically significant (n = 6, independent t test, p > 0.05) compared to that without PTX (−29.2 ± 6.0%). However, in the presence of the GABAB receptor antagonist CGP54626, the effect of GABA on the frequency of sEPSCs disappeared (Figure 6B). The average frequency of sEPSCs was 3.8 ± 0.4 Hz before and 3.8 ± 0.4 Hz for 10–15 min after GABA application in the presence of CGP54626 (2 µM) (n = 6 cells from four rats, paired t test, p > 0.05, compared to CGP54626 before GABA, right panel of Figure 6B). These results suggest that it is GABAB receptors, rather than GABAA receptors, that mediate the decreasing effect of GABA on presynaptic glutamate release in VTA-DA neurons. Figure 6 Download asset Open asset Influence of the GABAA receptor antagonist PTX and the GABAB receptor antagonist CGP54626 on the effect of exogenous application of GABA as well as the influence of the GABAB receptor antagonist CGP54626 on 470 nm light-induced inhibition of the frequency of sEPSCs in VTA-DA neurons. (A) Influence of the GABAA receptor antagon